HOME ABOUT US PRINT PUBLICATIONS SUBSCRIPTIONS CONTACT US RSS
 
Welcome to FDAweb
Pay Per View
Search our 68,697 - story database FREE
 
Free Items
 Warning Letters
 FDA Notices
 FDA Calendar
 

 FDA Whistleblowers



    








 
     
 
Comments Sought on ‘Enhanced Transparency’ Submissions
12/10/2015
 

Federal Register Notice: FDA is seeking public comment on a proposed information collection involving interviews of pharmaceutical manufacturers who submit new molecular entity NDAs and original BLAs to FDA under the Program for Enhanced Review Transparency and Communication during fiscal years 2013-2017. Comments should be submitted by 2/8. To view this notice, click here.

 
 
 
Any copying or electronic transfer without written permission is strictly prohibited and will result
in termination of service and prosecution under the federal Copyright Act.
To gain permission to copy this article log on to http://www.copyright.com.

FERDIC INCORPORATED - P.O. Box 28, Camp Hill, PA 17001 | Phone: (717)731-1426 fax:(717)731-1427 Email: info@fdaweb.com